US Stock MarketDetailed Quotes

ALXO ALX Oncology

Watchlist
  • 0.5100
  • -0.0203-3.83%
Close Apr 29 16:00 ET
  • 0.5100
  • 0.00000.00%
Post 18:42 ET
27.23MMarket Cap-0.20P/E (TTM)

About ALX Oncology Company

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.

Company Profile

SymbolALXO
Company NameALX Oncology
Listing DateJul 17, 2020
Issue Price19.00
Founded2015
CEOMr. Jason Lettmann
MarketNASDAQ
Employees80
Fiscal Year Ends12-31
Address323 Allerton Avenue
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-466-7125

Company Executives

  • Name
  • Position
  • Salary
  • Jason Lettmann
  • Chief Executive Officer and Director
  • 6.64M
  • Shelly Pinto
  • Senior Vice President, Finance and Chief Accounting Officer
  • 1.51M
  • Harish Shantharam
  • Chief Financial Officer
  • --
  • Dr. Alan B. Sandler, M.D.
  • Chief Medical Officer
  • 96.64K
  • Dr. Corey S. Goodman,PhD
  • Executive Chairman of the Board
  • 216.85K
  • Chris H. Takimoto, F.A.C.P.,M.D.,PhD
  • Independent Director
  • --
  • Dr. Barbara Klencke, M.D.
  • Independent Director
  • --
  • Rekha Hemrajani, M.B.A.
  • Independent Director
  • 186.83K
  • Scott Garland
  • Independent Director
  • 182.83K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.